Since May, more than 700 cases of monkey pox have been reported in countries beyond West and Central Africa where the virus is endemic.
Although mortality has not yet been reported, due to its extremely unusual prevalence, health officials around the world are trying to understand how the virus spreads and provide adequate vaccines and treatments if it speeds up.
“We look forward to seeing more cases and more tests in the coming days,” Raj Panjabi, senior director of global health security and biofuels, told a news briefing at the White House.
The World Health Organization said last week that the epidemic posed a “moderate” risk to global public health. On Thursday, Maria Van Kerkhove, who heads the World Health Organization’s Emerging Diseases and Zoonoses teams, said the organization suspects human-to-human transmission has been going on in Europe for weeks.
The CDC claims the risk is “low” for Americans, but conducts regular briefings on epidemic status. Most cases in the United States have been reported in men who are identified as gay, bisexual, or men who have sex with men, but health officials warn that the disease can be spread by close contact between any individual.
The federal government has distributed 1,200 chickenpox and monkeypox vaccines in eight states and 100 courses of treatment to establish close contact with monkeypox patients. More than 340 contacts of confirmed cases have been identified, more than 20 are considered at “high” risk, and more than 120 are considered at “intermediate” risk.
The first cases were reported in the United States in mid-May in Massachusetts and New York, and the following cases were confirmed in California, Colorado, Florida, Georgia, Illinois, Pennsylvania, Virginia, and Washington.
Federal health officials are urging doctors to submit samples from suspicious cases to a nationwide network of laboratories that can test for a monkey or orthopox, a related virus.
The National Strategic Reserve contains doses of two vaccines that can be used to prevent and treat monkeypox: a newer dosing vaccine approved for monkeypox and chickenpox called Jynneos, and an older vaccine that is approved for chickenpox but can be used for chickenpox. , Called ACAM2000.
On Friday, Assistant Secretary of State for Preparedness and Response Don O’Connell declined to say how many doses were in stock, citing national security concerns. “We have enough vaccines to control the current explosion,” he said.
O’Connell said the vaccines were deployed in SNS precincts across the country and that there were additional doses of Jynneos vaccine with the manufacturer, Bavarian Nordic.
Last month, the CDC said the SNS contained more than 1,000 doses of Jyenneos and more than 100 million doses of ACAM2000. The agency said Friday that Jynneos numbers were no longer accurate, but declined to elaborate on whether more or less doses were now available.
Daniel Payne contributed to this report.
More cases of monkey flower are expected as the CDC warns of the spread of the topic
Source link More cases of monkey flower are expected as the CDC warns of the spread of the topic